Outcomes of supraflex sirolimus eluting coronary stents
Background: The introduction of Sirolimus Eluting Coronary Stents (SES) was a major breakthrough in interventional cardiology. The large, randomized, clinical trials using SES have shown a remarkable reduction in angiographic restenosis and target vessel revascularization (TVR) compared with bare-me...
Main Authors: | Vishal Virendra Singh, Sheikh Mohammad Tahir, Sanjiv Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Applied Sciences and Clinical Practice |
Subjects: | |
Online Access: | http://www.jascp.org/article.asp?issn=2772-364X;year=2022;volume=3;issue=1;spage=25;epage=31;aulast=Singh |
Similar Items
-
Outcomes of supraflex Sirolimus-eluting coronary stents
by: Vishal Virendra Singh, et al.
Published: (2022-01-01) -
Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01) -
Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
by: Michał Hawranek, et al.
Published: (2021-12-01) -
Nine-Months Clinical Outcome of Biodegradable Polymer Coated Sirolimus-eluting Stent System: A Multi-Centre “Real-World” Experience
by: Raghava Sarma, et al.
Published: (2015-08-01) -
Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
by: Ryota Kakizaki, et al.
Published: (2020-10-01)